Kratom

FDA Issues Warning to Companies Selling Kratom-Containing Products

FDA Issues Warning to Companies Selling Kratom-Containing Products

By

The US Food and Drug Administration has issued warnings to 3 companies selling kratom-containing products with unsubstantiated claims regarding their effectiveness in conditions that include opioid withdrawal and addiction and chronic pain.

FDA Issues Mandatory Recall of Food Products Containing Powdered Kratom

FDA Issues Mandatory Recall of Food Products Containing Powdered Kratom

By

The recall is due to samples of the product testing positive for Salmonella.

Case Report Reveals Another Possible Side Effect of Kratom

Case Report Reveals Another Possible Side Effect of Kratom

By

According to the authors, this is the first report of kratom-induced hyperprolactinemia.

Kratom-Containing Dietary Supplements Recalled

Kratom-Containing Dietary Supplements Recalled

The FDA said it wants all companies making kratom products to take them off the market, and urged all consumers who have kratom-containing products to stop using them and throw them away.

FDA Concerned About Potential for Abuse, Addiction With Kratom

FDA Concerned About Potential for Abuse, Addiction With Kratom

By

An investigation of the 25 most prevalent compounds in kratom showed that these compounds share structural similarities with controlled opioid analgesics, such as morphine derivatives.

FDA Expresses Safety Concern Over Kratom

FDA Expresses Safety Concern Over Kratom

By

The Food and Drug Administration's Commissioner Scott Gottlieb, MD, has issued a statement regarding the deadly risks associated with the botanical substance, kratom.

What the Scheduling of Kratom by the DEA Means for Research

What the Scheduling of Kratom by the DEA Means for Research

By

The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.

Sign Up for Free e-Newsletters